“The Frontiers of Health: Where Wearables Meet Weirdness”

Getting Better: The Future of Home Medtech at CES

The Consumer Electronics Show (CES) has seen a plethora of innovations in the healthcare and technology sphere, with a focus on home medtech. One such innovation is the introduction of Abbott’s Lingo, a biosensor that can track glucose levels by inserting a small device under the skin. This non-invasive sensor is designed to provide real-time glucose monitoring for people with diabetes.

However, another significant announcement from Withings, a French digital health startup, is the launch of Cardio Checkup, an in-app service that can alert users to possible cases of atrial fibrillation (a type of irregular heartbeat) and provide access to specialists through the app. This service is compatible with all Withings devices that have ECG capabilities, such as the ScanWatch.

The Rise of Home Medtech

The pandemic has accelerated the growth of digital health innovations, with many companies jumping onto the bandwagon. However, 2024 has seen a significant pullback in the digital health industry, with many companies struggling to stay afloat. A CNBC analysis found that two-thirds of the 39 digital health public companies they studied were down for the year or out of business.

The reason behind this is that consumers have become more discerning, realizing that having access to health data is not enough. They need actionable insights and solutions to address the underlying issues that affect their health. As a result, many companies are focusing on providing more comprehensive solutions that can help individuals take control of their health.

The Lingo Biosensor: A Game-Changer in Diabetes Management

The Lingo biosensor is a small, non-invasive device that can be inserted under the skin to track glucose levels. It is designed to provide real-time monitoring, allowing individuals to make informed decisions about their diet and exercise routine. The sensor is simple to use, with an insertion process that takes only a few seconds.

In an era where medical technology is evolving at a rapid pace, the Lingo biosensor stands out as a game-changer in diabetes management. It offers a more convenient and non-invasive alternative to traditional methods, such as fingerpricking, which many people find painful and cumbersome.

Benefits of Cardio Checkup

Withings’ Cardio Checkup is another innovation that is gaining attention. This in-app service provides users with regular check-ups and access to specialists, making it an excellent tool for people with cardiovascular conditions. The ability to detect potential issues early on can save lives, and the service’s ease of use makes it accessible to a wide range of people.

Conclusion

The future of home medtech is bright, with innovations like the Lingo biosensor and Cardio Checkup leading the way. As consumers become more discerning, companies are responding by providing more comprehensive solutions that can help people take control of their health. Whether you’re managing diabetes or heart conditions, these innovations can provide a vital lifeline, offering actionable insights and peace of mind.

FAQs:

Q: What is the Lingo biosensor?
A: The Lingo biosensor is a small, non-invasive device that can be inserted under the skin to track glucose levels.

Q: What is Cardio Checkup?
A: Cardio Checkup is an in-app service that provides users with regular check-ups and access to specialists, helping to detect potential cardiovascular issues early on.

Q: Is the Lingo biosensor painful to use?
A: The Lingo biosensor is designed to be non-invasive and has a simple insertion process that takes only a few seconds. Some users may experience a slight sting or discomfort, but it is not typically painful.

Q: Can I use Cardio Checkup with any Withings device?
A: Yes, Cardio Checkup is compatible with all Withings devices that have ECG capabilities, including the ScanWatch.